Gilead Sciences Inc GILD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:43 PM EDT
76.51UNCH (UNCH)
Volume
229,783
Close
76.51quote price arrow up+3.01 (+4.10%)
Volume
11,480,934
52 week range
62.07 - 87.86
Loading...
  • Open74.75
  • Day High77.34
  • Day Low74.38
  • Prev Close73.50
  • 52 Week High87.86
  • 52 Week High Date01/19/24
  • 52 Week Low62.07
  • 52 Week Low Date05/31/24

Key Stats

  • Market Cap95.32B
  • Shares Out1.25B
  • 10 Day Average Volume6.58M
  • Dividend3.08
  • Dividend Yield4.03%
  • Beta0.20
  • YTD % Change-5.55

KEY STATS

  • Open74.75
  • Day High77.34
  • Day Low74.38
  • Prev Close73.50
  • 52 Week High87.86
  • 52 Week High Date01/19/24
  • 52 Week Low62.07
  • 52 Week Low Date05/31/24
  • Market Cap95.32B
  • Shares Out1.25B
  • 10 Day Average Volume6.58M
  • Dividend3.08
  • Dividend Yield4.03%
  • Beta0.20
  • YTD % Change-5.55

RATIOS/PROFITABILITY

  • EPS (TTM)0.36
  • P/E (TTM)212.76
  • Fwd P/E (NTM)11.32
  • EBITDA (TTM)12.858B
  • ROE (TTM)2.51%
  • Revenue (TTM)27.45B
  • Gross Margin (TTM)77.52%
  • Net Margin (TTM)1.66%
  • Debt To Equity (MRQ)143.65%

EVENTS

  • Earnings Date08/08/2024
  • Ex Div Date06/14/2024
  • Div Amount0.77
  • Split Date-
  • Split Factor-

Profile

MORE
Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. It is focused on the discovery, development and commercialization of medicines in areas of unmet medical need. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP...
Daniel O'Day
Chairman of the Board, Chief Executive Officer
Andrew Dickinson
Chief Financial Officer
Deborah Telman
Executive Vice President - Corporate Affairs, General Counsel
Address
333 LAKESIDE DR
Foster City, CA
94404
United States

Top Peers

SYMBOLLASTCHG%CHG
LLY
Eli Lilly and Co
821.19-38.69-4.50%
NVO
Novo Nordisk A/S
127.86-3.74-2.84%
JNJ
Johnson & Johnson
159.64+3.36+2.15%
MRK
Merck & Co Inc
125.85-0.07-0.06%
ABBV
AbbVie Inc
182.17+5.96+3.38%